MBIA insider to sell 25,086 shares via Charles Schwab on NYSE
Rhea-AI Filing Summary
MBIA Inc. submitted a Form 144 notice reporting a proposed Rule 144 sale of 25,086 common shares via Charles Schwab, with an aggregate market value of $148,509.12. The shares represent roughly 0.05% of the reported 50,488,741 shares outstanding. The filer acquired the securities through share grants: 8,584 shares on 05/15/2024 and 16,502 shares on 05/15/2025. The approximate sale date is listed as 08/11/2025 and the proposed execution venue is the NYSE. The notice states there were no reported sales in the past three months and includes the standard representation that the filer is not aware of undisclosed material adverse information.
Positive
- Transparent disclosure of a proposed sale of 25,086 shares with broker and exchange identified
- Securities were acquired as share grants rather than purchased, with acquisition dates provided
- No reported sales in the past three months, indicating this is not part of a recent wave of dispositions
- Proposed sale size is small (~0.05% of outstanding shares), implying limited market impact
Negative
- None.
Insights
TL;DR: Routine, small insider sale with negligible market impact given the tiny share fraction and grant-based acquisition.
The Form 144 shows a proposed sale of 25,086 common shares valued at $148,509.12, equal to about 0.05% of the 50,488,741 shares outstanding. All shares were acquired as share grants (05/15/2024 and 05/15/2025). No sales were reported in the prior three months. From a market-impact perspective, this quantity is immaterial to public float and unlikely to affect trading or valuation. The filing is a standard disclosure, not an operational update.
TL;DR: Disclosure aligns with Rule 144 procedures and includes the filer’s representation about material nonpublic information.
The notice identifies the broker (Charles Schwab) and specifies the approximate sale date (08/11/2025) and execution on the NYSE. It confirms acquisition via issuer share grants and explicitly states no sales in the past three months. The form also carries the standard attestation that the filer does not possess undisclosed material adverse information and references trading-plan representation language. These elements indicate compliance with routine insider reporting obligations.
FAQ
How many MBIA (MBI) shares are proposed for sale?
What is the aggregate market value of the proposed MBIA sale?
When were the shares acquired that are being proposed for sale?
When is the approximate date of the proposed sale for MBIA shares?
Which broker and exchange are named for the MBIA proposed sale?
Has the filer sold any MBIA securities in the past three months?